Epsilon Financial Statements From 2010 to 2024
| HDRPF Stock | USD 0 0.00 0.00% |
Check Epsilon Healthcare financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Epsilon Healthcare's main balance sheet or income statement drivers, such as , as well as many indicators such as . Epsilon financial statements analysis is a perfect complement when working with Epsilon Healthcare Valuation or Volatility modules.
Epsilon |
Epsilon Healthcare Limited Company Profit Margin Analysis
Epsilon Healthcare's Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Current Epsilon Healthcare Profit Margin | (2.41) % |
Most of Epsilon Healthcare's fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Epsilon Healthcare Limited is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
| Competition |
Based on the latest financial disclosure, Epsilon Healthcare Limited has a Profit Margin of -2.4105%. This is 78.5% lower than that of the Healthcare sector and significantly lower than that of the Drug Manufacturers—Specialty & Generic industry. The profit margin for all United States stocks is 89.8% higher than that of the company.
Epsilon Healthcare Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Epsilon Healthcare's current stock value. Our valuation model uses many indicators to compare Epsilon Healthcare value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Epsilon Healthcare competition to find correlations between indicators driving Epsilon Healthcare's intrinsic value. More Info.Epsilon Healthcare Limited is one of the top stocks in return on equity category among its peers. It also is one of the top stocks in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Epsilon Healthcare's earnings, one of the primary drivers of an investment's value.About Epsilon Healthcare Financial Statements
Epsilon Healthcare stakeholders use historical fundamental indicators, such as Epsilon Healthcare's revenue or net income, to determine how well the company is positioned to perform in the future. Although Epsilon Healthcare investors may analyze each financial statement separately, they are all interrelated. For example, changes in Epsilon Healthcare's assets and liabilities are reflected in the revenues and expenses on Epsilon Healthcare's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Epsilon Healthcare Limited. Please read more on our technical analysis and fundamental analysis pages.
Epsilon Healthcare Limited operates as a healthcare and pharmaceuticals company primarily in Australia and Canada. Epsilon Healthcare Limited was incorporated in 2016 and is based in Sydney, Australia. Epsilon Healthcare operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange.
Currently Active Assets on Macroaxis
Other Information on Investing in Epsilon Pink Sheet
Epsilon Healthcare financial ratios help investors to determine whether Epsilon Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Epsilon with respect to the benefits of owning Epsilon Healthcare security.